Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
15,392,157
-
Total 13F shares
-
16,089,357
-
Share change
-
+2,273,685
-
Total reported value
-
$367,798,844
-
Put/Call ratio
-
234%
-
Price per share
-
$22.86
-
Number of holders
-
86
-
Value change
-
+$14,465,355
-
Number of buys
-
51
-
Number of sells
-
40
Institutional Holders of Neurogene Inc. - Common Stock (NGNE) as of Q4 2024
As of 31 Dec 2024,
Neurogene Inc. - Common Stock (NGNE) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,089,357 shares.
The largest 10 holders included
Samsara BioCapital, LLC, BlackRock, Inc., RTW INVESTMENTS, LP, Redmile Group, LLC, Casdin Capital, LLC, EcoR1 Capital, LLC, FMR LLC, COMMODORE CAPITAL LP, BAKER BROS. ADVISORS LP, and VANGUARD GROUP INC.
This page lists
86
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.